Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OneLegacy is a nonprofit organ, eye, and tissue recovery organization serving Southern California. It is not a drug-development biotech or pharmaceutical company; rather, it coordinates donor referral, family authorization, clinical recovery, preservation, allocation, and logistics for transplantation and tissue donation. The organization works with hospitals, physicians, transplant centers, and community partners across its service area and is widely described as the nation’s largest organ procurement organization. OneLegacy also conducts public education and donor registration outreach through Donate Life-related programs and community initiatives. For a biotech analyst, the key point is that OneLegacy operates in transplant services and human tissue recovery, not in therapeutic R&D with a conventional product pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OneLegacy.